make money with digital currency, See results about

Greece negotiated in advance to buy 36 sets of PULS rocket launcher systems from Israel, worth 600 million to 700 million euros.US Secretary of State Blinken visited Baghdad to discuss the Syrian issue with Iraqi Prime Minister. On December 13th, local time, US Secretary of State Blinken visited the Iraqi capital Baghdad and held talks with Iraqi Prime Minister Al-Sudani on the Syrian issue. The State Council has not announced the itinerary of Blinken's visit before.The pharmacy chain WBA rose to 4%. It is reported that Sycamore Partners LP is arranging a debt financing plan for the acquisition of WBA. Sycamore has contacted lenders such as Bank of America and JPMorgan Chase.

GBP/USD fell more than 0.50% in the day, and now it is reported at 1.2611.Market News: Belarusian President Lukashenko approved the budget of Belarus in 2025.European natural gas futures fell by more than 11% this week, and the EU carbon tax fell by about 6%. At the end of the European market on Friday (December 13th), ICE UK natural gas futures fell by 3.41% to 102.560p/kcal, with a cumulative decline of 11.49% this week. TTF benchmark Dutch natural gas futures fell 3.57% to 41.030 Euro/MWh, down 11.67% this week. ICE EU carbon emissions trading license (futures price) fell 2.80% to 64.25 euros/ton, down 5.94% this week.

The Russell 2000 index fell by 1% in the day.The statement showed that US House of Representatives member Pelosi was injured and was taken to Luxembourg Hospital. It is reported that Pelosi has received good treatment and will continue to work.The latest research results support Harvard's discovery that Novo Nordisk diet drug Ozempic is related to rare visual loss, and the large-scale test results show that Novo Nordisk diet drug Ozempic is related to rare visual loss, which supports the research results given by Harvard University earlier this year. Obese patients who use Ozempic are more than twice as likely to be diagnosed with NAION. NAION occurs when the blood flow decreases and damages the optic nerve. The risk of eye conditions is still low; Patients should pay attention. Novo Nordisk Denmark's share price once fell more than 3.3%.